The growing market for digital breast tomosynthesis systems, along with rising demand for secondary diagnostic modalities such as dedicated breast MRI and BSGI as adjuncts for mammography screening, will drive growth of the global breast imaging system market though 2027.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for breast imaging systems globally across a 10-year period.
The breast imaging system market will grow through 2027 due to the rising adoption of secondary breast diagnostic modalities.
How will the uncertainty over breast screening guidelines and the issue of screening dense breast tissue affect demand in this market?
How will the uptake of secondary screening technologies, such as dedicated breast MRI and breast ultrasound, affect this market?
The rapidly expanding DBT segment will heavily impact the overall market for breast imaging systems.
Which vendors are active in this segment and how do they compete?
What implications follow the growing interest of DBT, both as a supplementary diagnostic tool and as a potential replacement for mammography screening?
ASPs are declining due to price competition.
What factors will mitigate price erosion?
Which countries will be most affected by this trend?
How significantly will this trend affect market potential?
- Breast Imaging Systems - Market Insights - Global
Author(s): Sumit Jain, MS Pharm
Sumit Jain is an analyst within the Endoscopy, Diagnostics, and Healthcare IT Medtech Insights team at Decision Resources Group, focusing on diagnostic imaging capital equipment and healthcare IT markets. Sumit holds a Bachelor's degree in Pharmacy from the Rajiv Gandhi Technical University, Bhopal, and a Master's degree in Pharmacoinformatics from the National Institute of Pharmaceutical Education and Research, Mohali.